Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
28.13
+0.32 (1.15%)
At close: Dec 5, 2025, 4:00 PM EST
28.11
-0.02 (-0.07%)
After-hours: Dec 5, 2025, 7:57 PM EST
Legend Biotech Revenue
Legend Biotech had revenue of $272.33M in the quarter ending September 30, 2025, with 69.99% growth. This brings the company's revenue in the last twelve months to $909.05M, up 74.75% year-over-year. In the year 2024, Legend Biotech had annual revenue of $627.24M with 119.97% growth.
Revenue (ttm)
$909.05M
Revenue Growth
+74.75%
P/S Ratio
5.69
Revenue / Employee
$348,427
Employees
2,609
Market Cap
5.20B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LEGN News
- 10 days ago - Legend Biotech: Is Carvykti Changing Cancer Treatment Forever? - Seeking Alpha
- 22 days ago - Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - GlobeNewsWire
- 23 days ago - Legend Biotech Corporation (LEGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results - GlobeNewsWire
- 2 months ago - US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy - Reuters
- 2 months ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 3 months ago - Legend Biotech Corporation (LEGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha